Black Diamond Therapeutics Inc (BDTX)
2.99
+0.10
(+3.46%)
USD |
NASDAQ |
Nov 04, 16:00
2.98
-0.01
(-0.33%)
After-Hours: 20:00
Black Diamond Therapeutics Market Cap: 168.95M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 168.95M |
| November 01, 2024 | 163.30M |
| October 31, 2024 | 154.82M |
| October 30, 2024 | 162.17M |
| October 29, 2024 | 161.60M |
| October 28, 2024 | 164.99M |
| October 25, 2024 | 168.38M |
| October 24, 2024 | 171.77M |
| October 23, 2024 | 172.90M |
| October 22, 2024 | 187.03M |
| October 21, 2024 | 181.38M |
| October 18, 2024 | 187.03M |
| October 17, 2024 | 181.95M |
| October 16, 2024 | 192.12M |
| October 15, 2024 | 192.12M |
| October 14, 2024 | 196.64M |
| October 11, 2024 | 188.16M |
| October 10, 2024 | 194.38M |
| October 09, 2024 | 200.59M |
| October 08, 2024 | 200.87M |
| October 07, 2024 | 206.81M |
| October 04, 2024 | 211.89M |
| October 03, 2024 | 206.81M |
| October 02, 2024 | 225.17M |
| October 01, 2024 | 235.63M |
| Date | Value |
|---|---|
| September 30, 2024 | 245.80M |
| September 27, 2024 | 239.02M |
| September 26, 2024 | 249.19M |
| September 25, 2024 | 237.32M |
| September 24, 2024 | 258.79M |
| September 23, 2024 | 254.27M |
| September 20, 2024 | 268.96M |
| September 19, 2024 | 270.09M |
| September 18, 2024 | 267.27M |
| September 17, 2024 | 272.64M |
| September 16, 2024 | 306.26M |
| September 13, 2024 | 349.77M |
| September 12, 2024 | 330.55M |
| September 11, 2024 | 346.09M |
| September 10, 2024 | 342.42M |
| September 09, 2024 | 319.82M |
| September 06, 2024 | 305.13M |
| September 05, 2024 | 315.30M |
| September 04, 2024 | 317.56M |
| September 03, 2024 | 326.03M |
| August 30, 2024 | 344.68M |
| August 29, 2024 | 345.24M |
| August 28, 2024 | 359.65M |
| August 27, 2024 | 354.29M |
| August 26, 2024 | 371.52M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
46.19M
Minimum
Oct 13 2022
1.609B
Maximum
Jun 22 2020
440.74M
Average
249.60M
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 91.08B |
| Ligand Pharmaceuticals Inc | 2.011B |
| Agios Pharmaceuticals Inc | 2.554B |
| ADMA Biologics Inc | 4.454B |
| AnaptysBio Inc | 547.34M |
Market Cap Related Metrics
| Price to Book Value | 1.517 |
| Price | 2.99 |
| Earnings Yield | -50.34% |